Impact of heat treatment on size, structure, and bioactivity of elemental selenium nanoparticles by Zhang, Jinsong et al.
© 2012 Zhang et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2012:7 815–825
International Journal of Nanomedicine
Impact of heat treatment on size, structure, and 
bioactivity of elemental selenium nanoparticles
Jinsong Zhang1
Ethan W Taylor2
Xiaochun Wan1
Dungeng Peng3
1School of Tea and Food Science, 
Anhui Agricultural University, 
Anhui, People’s Republic of China; 
2Department of Nanoscience, 
Joint School of Nanoscience and 
Nanoengineering, University of North 
Carolina at Greensboro, Greensboro, 
NC, 3Department of Biochemistry, 
Vanderbilt University, Nashville,  
TN, USA
Correspondence: Jinsong Zhang 
School of Tea and Food Science, Anhui 
Agricultural University, Hefei 230036, 
Anhui, People’s Republic of China 
Tel +86 551 578 6283 
Fax +86 551 578 6283 
Email zjs@ahau.edu.cn 
 
Dungeng Peng 
Department of Biochemistry,  
Vanderbilt University, Nashville,  
TN 37232, USA 
Email dgpeng@gmail.com
Background: Elemental selenium nanoparticles have emerged as a novel selenium source with 
the advantage of reduced risk of selenium toxicity. The present work investigated whether heat 
treatment affects the size, structure, and bioactivity of selenium nanoparticles.
Methods and results: After a one-hour incubation of solution containing 80 nm selenium 
particles in a 90°C water bath, the nanoparticles aggregated into larger 110 nm particles and 
nanorods (290 nm × 70 nm), leading to significantly reduced bioavailability and phase II 
enzyme induction in selenium-deficient mice. When a solution containing 40 nm selenium 
nanoparticles was treated under the same conditions, the nanoparticles aggregated into larger 
72 nm particles but did not transform into nanorods, demonstrating that the thermostability of 
selenium   nanoparticles is size-dependent, smaller selenium nanoparticles being more resistant 
than larger selenium nanoparticles to transformation into nanorods during heat treatment.
Conclusion: The present results suggest that temperature and duration of the heat process, as 
well as the original nanoparticle size, should be carefully selected when a solution containing 
selenium nanoparticles is added to functional foods.
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Introduction
Selenium has multiple beneficial effects for human health, through regulation of at 
least 25 selenoproteins all containing selenocysteine, the 21st genetically encoded 
protein amino acid.1 Among these selenoproteins, the glutathione peroxidase and 
thioredoxin reductase families are well characterized. Glutathione peroxidases 
  catalyze the reduction of hydrogen peroxide and a variety of organic hydroperoxides, 
including phospholipid hydroperoxide, to water and corresponding alcohols, using 
glutathione as the hydrogen donor.2 Thioredoxin reductases exert antioxidant actions 
through catalyzing the reduction of oxidized thioredoxin, using nicotinamide-adenine 
dinucleotide phosphate (NADPH) as the electron donor, or by directly reacting with 
hydrogen peroxide and hydroperoxides.3 Variations in selenoprotein genes have been 
found to be associated with increased cancer risk.4,5 Transgenic mice with reduced 
selenoprotein expression manifest precancerous changes.6,7 Human studies have shown 
reduced cancer risk and DNA damage after selenium supplementation among those 
with lower basal plasma selenium.8–10 These studies argue for a cancer-preventive 
effect of selenium at nutritional levels in selenium-deficient populations.
Like various other naturally occurring chemopreventive agents, such as   sulforaphane, 
curcumin, resveratrol, and epigallocatechin gallate, selenium at supranutritional lev-
els (which are roughly 10–30-fold higher than nutritional levels) is also capable of 
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inducing phase II detoxification enzymes, such as glutathi-
one S-transferase and quinone reductase.11–15 The resulting 
enhanced detoxification many contribute to the powerful 
chemopreventive effects exhibited by supranutritional sele-
nium, which have been observed in approximately 100 small 
animal studies.8,16,17 Since supranutritional selenium levels 
are close to the toxic selenium levels in general,8,16,17 the 
safety margin and potential toxic effects of different selenium 
compounds are critical considerations when evaluating their 
potential for supplementation.
Bulk red elemental selenium particles at the redox state 
of zero found in some bacteria are biologically inert.18 It is 
known that elemental selenium atoms can be formed in the 
redox system of sodium selenite and glutathione at the molar 
ratio of 1:4.19 We have demonstrated that the presence of a 
protein such as bovine serum albumin in the redox system 
can control the aggregation of neonatal elemental selenium 
atoms, thus inhibiting the formation of bulky red elemental 
selenium particles, and consequently leading to the formation 
of red elemental selenium nanoparticles.20 Compared with 
several extensively studied selenium compounds, ie, sodium 
selenite, selenomethionine, and methylselenocysteine, sele-
nium nanoparticles show markedly lower acute toxicity and 
significantly lower short-term and subchronic toxicities, 
but all these selenium compounds have equivalent efficacy 
in their ability to increase selenoenzymes.20–25 Furthermore, 
selenium nanoparticles appear to be more efficient than 
sodium selenite and selenomethionine in increasing glu-
tathione S-transferase activity,21,25 and seem to be equally 
efficient in inducing apoptosis of certain types of cancer cells 
as methylseleninic acid, a metabolite of methylselenocysteine 
that is considered to be the most promising selenium com-
pound in cancer prevention.26 Selenium nanoparticles may 
enhance selenium permeation and retention in tumor tissues 
because their blood vessels contain enlarged pore sizes rang-
ing from 100 nm to 800 nm, in stark contrast with the pore 
sizes of 2 nm to 6 nm in the vessels of healthy tissues.27 In 
addition to cancer prevention, selenium nanoparticles also 
show potential as antimicrobial agents.28
Selenium nanoparticles have emerged as a novel selenium 
source with the obvious advantage of reduced risk of sele-
nium toxicity.20–25,29,30 Accordingly, a selenium nanoparticle 
solution may be added to functional foods, the final products 
of which may be subjected to heat during processing. An 
important feature of nanoparticles is their high surface to 
volume ratio. As the nanosize decreases, surface atomic-
ity, surface energy, and surface binding energy all increase 
quickly; as a result, the surface atoms become more prone to 
diffusion, with an inherent tendency to combine with other 
atoms for energy dissipation. Hence, the thermodynamic 
properties and stability of nanoparticles should be affected 
by particle size and heat treatment.31–33 The thermal stability 
of selenium nanoparticles as a type of nanoscale biomaterial 
remains unknown. Herein, we investigated the impact of heat 
treatment on the size, structure, and bioactivity of selenium 
nanoparticles. We found that heat treatment causes selenium 
nanoparticles to aggregate into larger sizes and nanorods, 
leading to significantly reduced bioactivity in mice. The 
thermostability of selenium nanoparticles is size-dependent, 
smaller selenium nanoparticles being more resistant than 
larger selenium nanoparticles to transformation into nanorods 
during heat treatment.
Materials and methods
Chemicals
NADPH, dithio-bis-nitrobenzoic acid, glutathione, 
4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), insulin, thioredoxin (Escherichia coli), guanidine 
hydrochloride, bovine serum albumin, 1-chloro-2,4-dini-
trobenzene, and 2,3-diaminonaphthalene were all purchased 
from Sigma (St Louis, MO). Other chemicals, including 
hexamethylene, hydroxylamine hydrochloride, nitric acid, 
and perchloric acid, were of the highest grade available.
Solution-based preparations of selenium 
nanoparticles of two sizes
One mL of 25 mM sodium selenite was mixed with 4 mL 
25 mM of glutathione containing either 2 mg or 20 mg bovine 
serum albumin. The mixture pH was adjusted to 7.2 with 
1.0 M sodium hydroxide to generate red elemental selenium 
and oxidized glutathione.20 The red solution was dialyzed 
for 96 hours at 4°C against double distilled water which was 
replaced every 24 hours to separate oxidized glutathione from 
the selenium nanoparticles. The final solution containing sele-
nium nanoparticles and bovine serum albumin was stored in a 
4°C refrigerator, in which the selenium nanoparticle solution 
prepared using the low concentration of bovine serum albumin 
was stable for several months, and the selenium nanoparticle 
solution prepared by using the high concentration of bovine 
serum albumin was stable for several years.
Nanoparticle observation
A droplet of selenium nanoparticle solution was dropped 
onto copper grids and allowed to dry in air before observation 
under a high resolution transmission electron microscope. 
The average sizes of selenium nanoparticles prepared using 
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the low and high concentrations of bovine serum albumin 
were 80 nm (45 nm ~ 95 nm) and 40 nm (20 nm ~ 55 nm), 
respectively.
Animals and treatments
Selenium-deficient male Kunming mice (21–22 g) and 
their selenium-deficient diet were all purchased from the 
animal center in Anhui Medical University. The mice were 
housed in plastic cages in a room with controlled tempera-
ture (22°C ± 1°C) and humidity (50% ± 10%) on a 12-hour 
light/dark cycle. The mice were allowed to obtain food and 
water ad libitum. All experiments involving the mice were 
performed in compliance with the ethical guidelines issued 
by the Anhui Agriculture University.
Nutritional level of selenium
In the bioavailability experiment, 15 mice were divided into 
three groups (n = 5): the control group was administered 
oral saline; the other two groups were orally given selenium 
nanoparticles, either unheated or heated, at a selenium dose 
of 100 µg/kg body weight for 7 days.
Supranutritional level of selenium
In the supranutritional dose experiment, 24 mice were divided 
into three groups (n = 8): the control group was administered 
oral saline; the other two groups were administered oral sele-
nium nanoparticles, either unheated or heated, at a selenium 
dose of 2000 µg/kg body weight for 7 days.
Biomarkers
At the end of each set of experiments, the mice were sac-
rificed by cervical dislocation. Peripheral blood from the 
ophthalmic veins was collected into tubes to obtain blood and 
plasma after centrifugation. The livers were excised immedi-
ately and rinsed in ice-cold saline. The samples were stored 
at -30°C before assay. Liver tissues were homogenized in 
ice-cold 150 mM and pH 7.2 phosphate-buffered saline 
containing 1 mM EDTA-Na2 (1:9, w/v), and the homogenate 
was then centrifuged at 15,000 g and 4°C for 15 minutes. The 
resulting supernatants were used for determination of soluble 
protein levels with bovine serum albumin as standard,34 and 
for determination of glutathione peroxidase, thioredoxin 
reductase, and glutathione S-transferase activity.
Glutathione peroxidase activity assay
Glutathione peroxidase was assayed using the method of 
Rotruck et al.35 Glutathione peroxidase activity was expressed 
as units/mg protein or units/mL plasma; one unit of the 
activity was calculated in terms of 1 µmol of glutathione 
oxidized per minute.
Glutathione S-transferase activity assay
Glutathione S-transferase activity was chemically determined 
at 340 nm using 1-chloro-2,4-dinitrobenzene as the substrate. 
Glutathione S-transferase activity was expressed as units/
minute/mg protein; one unit of activity was calculated in 
terms of nmol of 1-chloro-2,4-dinitrobenzene changed per 
minute.36
Thioredoxin reductase activity assay
Thioredoxin reductase activity was measured based on 
the method of Holmgren and Björnstedt37 with some 
  modifications. A stock mixture was composed of HEPES 
buffer (1.0 M, pH 7.6), EDTA (0.2 M), NADPH (40 mg/mL), 
and bovine insulin (10 mg/mL) in a volume ratio of 
5:1:1:12.5. In a 96-well plate, 3 µL thioredoxin (2 mg/mL), 
7 µL stock mixture, 40 µL HEPES (50 mM, pH 7.6), and 
20 µL liver homogenate (with 20–30 µg protein) were added 
to each well. The enzymatic reaction was maintained at 37°C 
for 20 minutes, and then terminated by adding 240 µL stop 
solution containing 0.2 mg/mL dithio-bis-nitrobenzoic acid, 
6 M guanidine hydrochloride, and 0.2 M Tris at pH 8.0. Each 
sample contained a nonenzymatic reaction as the control. 
The nonenzymatic reaction included all components except 
thioredoxin, which was replaced by the same volume of 
saline. The 96-well plates were read at 412 nm. The absor-
bance of the control was subtracted from the absorbance of 
the sample. A background control, which was the subtraction 
of absorbance with and without thioredoxin in the absence of 
liver homogenate, was further subtracted from all samples. 
Thioredoxin reductase activity unit was defined as A412 
change × 1000 per minute and thioredoxin reductase activity 
was expressed as U/mg protein.38
Selenium assay
Selenium was assayed by a fluorescence method.39 Samples 
were digested using the mixture of nitric acid and perchloric 
acid at the ratio of 3:1 (v/v), then reacted with 2,3-diaminon-
aphthalene at 60°C for 30 minutes, then finally extracted with 
hexamethylene. The fluorescence intensity excited at 378 nm 
and recorded at 512 nm was used for calculating selenium 
concentration with sodium selenite as a standard.
Statistical analysis
Data are presented as the mean ± standard error of the mean. 
The differences between groups were examined by one-way 
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analysis of variance post hoc Tukey test, using GraphPad 
Software (Prism version 5, San Diego, CA). P , 0.05 was 
considered to be statistically significant.
Results
Impact of heat treatment
Size and structure of 80 nm selenium nanoparticles
A sealed glass tube with 10 mL of the 80 nm selenium 
  nanoparticle solution was incubated in a 1000 mL water bath 
at 90°C for one hour, and then the hot glass tube was cooled 
in an ice bath to room temperature. Under inspection by high 
resolution transmission electron microscopy, it was found 
that the selenium nanoparticles changed substantially due to 
heat treatment. As shown in Figure 1A, selenium particles in 
the precursor unheated selenium nanoparticle solution were 
spherical nanoparticles with an average size of 80 nm ranging 
from 45 nm to 95 nm, whereas in the heated selenium nanopar-
ticle solution (Figure 1B), the precursor selenium nanoparticles 
were replaced by both enlarged nanoparticles with an average 
size of 110 nm ranging from 70 nm to 120 nm and nanorods, 
the average dimension of which was 290 nm × 70 nm.
Bioavailability of 80 nm selenium nanoparticles
The primary purpose of this study was to investigate the 
impact of heat treatment on the bioactivity of selenium 
  nanoparticles. One of the most fundamental   properties 
of selenium compounds is bioavailability in terms of 
  increasing selenoenzyme activity and tissue selenium 
  levels. We have shown that oral administration of selenium 
  nanoparticles to selenium-deficient mice at doses of 35, 70, 
and 1000 µg/kg for one week dose-dependently increased 
selenoenzyme activity and tissue selenium levels.21 Thus, 
in the present study, we used selenium 100 µg/kg, which 
is a typical   selenium nutritional dose, for one-week oral 
  supplementation. As compared with the control (Figure 2A), 
the unheated 80 nm selenium nanoparticles significantly 
(P , 0.001) increased hepatic glutathione peroxidase   activity 
by 5.7-fold, whereas the heated selenium nanoparticles 
significantly increased the activity (P , 0.01), but only by 
3.0-fold; accordingly, a significant difference (P , 0.01) 
existed between the two selenium   nanoparticle groups. As 
compared with the control (Figure 2B), the unheated 80 nm 
selenium nanoparticles significantly (P , 0.01) increased 
hepatic thioredoxin reductase activity by 1.9-fold. In contrast, 
the heated selenium   nanoparticles did not significantly alter 
the activity; consequently, a significant difference (P , 0.01) 
existed between the two selenium nanoparticle groups. As 
compared with the control (Figure 2C), the unheated 80 nm 
selenium nanoparticles significantly (P , 0.001) increased 
hepatic selenium by 2.0-fold, whereas the heated selenium 
nanoparticles significantly (P , 0.05) increased the selenium 
level, but only by 1.5-fold; accordingly, a significant differ-
ence (P , 0.05) existed between the two selenium nano-
particle groups. As compared with the control (Figure 2D), 
the unheated 80 nm selenium nanoparticles significantly 
(P , 0.001) increased plasma glutathione peroxidase activ-
ity by 2.3-fold, whereas the heated selenium nanoparticles 
significantly (P , 0.01) increased the activity, but only by 
1.7-fold; accordingly, a significant difference (P , 0.05) 
existed between the two selenium nanoparticle groups. 
Coincidentally, plasma selenium levels almost completely 
mirrored the alterations found in plasma glutathione per-
oxidase (Figure 2D). These results clearly demonstrate that 
the heat treatment significantly reduced bioavailability of the 
80 nm selenium nanoparticles.
Glutathione S-transferase induction  
and selenium retention of 80 nm nanoparticles  
at a supranutritional level
Another important bioactivity of selenium, in addition to 
bioavailability, is its impact on phase II enzymes. We have 
shown that oral administration of selenium nanoparticles to 
selenium-deficient mice at supranutritional selenium doses of 
500 and 2000 µg/kg for one week dose-dependently increased 
glutathione S-transferase activity and tissue selenium levels.40 
Thus, in the present study, we used selenium 2000 µg/kg 
for one week as oral supplementation. As compared with 
the control (Figure 3A), the unheated 80 nm selenium 
nanoparticles significantly (P , 0.001) increased hepatic 
glutathione S-transferase activity by 1.6-fold. In contrast, 
heated 80 nm selenium nanoparticles did not alter the activity; 
consequently, a significant difference (P , 0.001) existed 
between the two selenium nanoparticle groups. As compared 
A  B 
170 nm 170 nm
Figure 1 Heat treatment changes the size and the structure of 80 nm selenium 
nanoparticles.  (A)  Unheated  precursor  selenium  nanoparticles.  (B)  Precursor 
selenium nanoparticle solution after heating at 90°C for one hour.
Note: The bar in A and B represents 170 nm.
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with the control (Figure 3B), the unheated 80 nm selenium 
  nanoparticles significantly (P , 0.001) increased hepatic 
selenium by 8.9-fold, whereas the heated selenium nanopar-
ticles significantly (P , 0.001) increased the selenium levels, 
but only by 6.6-fold; accordingly, a significant difference 
(P , 0.001) existed between the two selenium nanoparticle 
groups. As compared with the control (Figure 3C), both the 
unheated and the heated selenium nanoparticles caused a 
highly significant (all P , 0.001) massive increase in hepatic 
glutathione peroxidase activity, by 38.8-fold and 34.2-fold, 
respectively. However, as expected, no significant differences 
were found between the two selenium nanoparticle groups, 
because selenoenzymes, including hepatic glutathione per-
oxidase, can be fully saturated at the upper end of   nutritional 
selenium levels. Although the heated 80 nm   selenium 
  nanoparticles showed an approximately 50% reduced effi-
cacy in increasing hepatic glutathione peroxidase activity at 
100 µg selenium/kg as compared with the unheated mate-
rial (  Figure 2A), in this case a 20-fold increase of selenium 
amounts should fully compensate for this defect.
Size and structure of 40 nm selenium nanoparticles
The 40 nm selenium nanoparticles were treated with heat 
under the same conditions and for the same duration as the 
80 nm selenium nanoparticles. Under inspection by high 
resolution transmission electron microscopy, as shown in 
Figure 4A, the selenium particles in the unheated selenium 
nanoparticle solution were spherical, with an average size of   
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Figure 2 Heat treatment reduces bioavailability of 80 nm selenium nanoparticles at a nutritional level. Selenium-deficient mice were orally administered with saline as a 
control, or 80 nm selenium nanoparticles, either unheated or heated, at a selenium dose of 100 µg/kg for 7 days.
Notes Compared with the controls, *P , 0.05; **P , 0.01; ***P , 0.001.
Abbreviations: GPx, glutathione peroxidase; TxR, thioredoxin reductase.
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40 nm, ranging from 20 nm to 55 nm, whereas in the heated 
selenium nanoparticle solution (Figure 4B), enlarged nanopar-
ticles with an average size of 70 nm were observed. In stark 
contrast with heat-activated evolution of the 80 nm   selenium 
nanoparticles, in this case nanorods were not observed. 
Strikingly, the enlarged selenium nanoparticles had a 
surprisingly narrow size distribution ranging from 68 nm to 
72 nm, highly faceted morphology, and uniform edge-to-edge 
distances between particles relative to the untreated precur-
sor nanoparticles (Figure 4A and B). These contrasts could 
be more clearly seen from the photos with enhanced resolu-
tion (Figure 4C for the unheated selenium nanoparticles and 
Figure 4D for the heated selenium nanoparticles).
Discussion
Elemental selenium nanoparticles can be formed natu-
rally in certain bacteria,41–43 and can be prepared through 
inorganic selenium reduction in the presence of protein or 
polysaccharide.20,44–46 Various sizes of selenium nanoparticles 
can be obtained by changing the concentration of a protein 
such as bovine serum albumin.47,48 Generally, the higher the 
bovine serum albumin concentration, the smaller the selenium 
nanoparticle size.47,48 Accordingly, in the present study, 40 nm 
and 80 nm selenium nanoparticles were prepared by adding 
low or high concentrations of bovine serum albumin to the 
redox system of sodium selenite and glutathione.
Nanoparticles have an inherent tendency to grow into 
larger particles. In general, a smaller nanoparticle with a 
lower melting point grows uniformly, until it becomes stable 
at a specific heat treatment temperature through thermody-
namic control.32,33 Maye et al and Maye and Zhong, have 
investigated the effect of heat treatment on the manipulation 
of the size and shape of alkanethiol-protected gold nanopar-
ticles in solution.32,33 The precursor gold nanoparticles they 
used showed an average core size of 2.0 nm with a wide 
size distribution; in addition, the particle shapes were not 
uniform. After heat treatment, the sizes of gold nanoparticles 
increased, and, in sharp contrast with the morphological 
features of the precursor nanoparticles, the enlarged nano-
particles evolved from heat treatment showed three striking 
features, ie, a much   narrower size distribution, highly faceted 
outlines, and uniform   spacing between the nanoparticles.32,33 
Interestingly, in the present study, we observed generally 
similar evolutions using the 40 nm selenium nanoparticle 
solution. After the 40 nm selenium nanoparticle solution was 
subjected to 1 hour of heat treatment at 90°C, the enlarged 
nanoparticles displayed obvious alterations of shape and 
homogeneity in   comparison with the precursor nanoparticles 
(Figure 4A and B). Three typical morphological features were 
evident: first, a much narrower size distribution; second, the 
predominance of   faceted particles with pentagon or hexagon 
outlines exhibiting three-dimensional profiles; and third, 
uniform   edge-to-edge distances.
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Figure 3 Heat treatment reduces the bioactivity of 80 nm selenium nanoparticles 
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However, the evolution of the 80 nm selenium nano-
particles on heat treatment was radical, with both faceted 
nanoparticles and nanorods being formed after 1 hour of 
heat treatment at 90°C (Figure 1B). Faceted nanoparticles 
may evolve, as with the 40 nm selenium nanoparticles, from 
the smaller 45 nm nanoparticles that are still present in the 
90 nm selenium nanoparticles (Figure 1A), whereas the 
nanorods may evolve from the larger 95 nm nanoparticles 
in the 90 nm selenium nanoparticles (Figure 1A). Because 
bovine serum albumin concentration in the 80 nm selenium 
nanoparticles is 10-fold lower than that in the 40 nm sele-
nium nanoparticles, it may be argued that the extra protein 
may prevent the formation of nanorods. However, this 
possibility was ruled out, because when we added bovine 
serum albumin to preformed 80 nm selenium nanopar-
ticles at the same bovine serum albumin concentration as 
that in the 40 nm selenium nanoparticles, we found heat 
treatment at 90°C still resulted in formation of nanorods. 
Thus, the thermally-activated size and structure evolutions 
are considered to be dependent on precursor particle size, 
with smaller selenium nanoparticles being more resistant 
than larger selenium nanoparticles to transformation into 
nanorods during heat treatment.
In the present study, we only investigated the impact of 
heat treatment on bioactivity of the 80 nm selenium nanopar-
ticles, without addressing the issue using the 40 nm selenium 
nanoparticles. This selection was based on two reasons. First, 
the bioactivity of nanorods generated from the 80 nm selenium 
nanoparticles is completely unknown. Second, we have eluci-
dated size effects of selenium nanoparticles in vitro, in a cell 
model, and in vivo, using different sizes ranging from 10 nm 
to 200 nm,40,47,48 and the sizes of both the precursor 44 nm sele-
nium nanoparticles and the heated material fall into this range. 
Our previous studies have demonstrated that different sizes of 
170 nm 170 nm
80 nm 80 nm
A
C 
B  
D
Figure 4 Heat treatment changes the morphology of 40 nm selenium nanoparticles. (A) and (C) Unheated precursor selenium nanoparticles. (B) and (D) Precursor selenium 
nanoparticle solution after heating at 90°C for one hour.
Note: The bar in A and B represents 170 nm, and in C and D represents 80 nm.
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selenium nanoparticles have no differences in bioavailability 
in both a cell model and in an in vivo model,47 but selenium 
nanoparticles of small size gain advantages in their ability to 
scavenge multiple free radical species in vitro,48 and to enhance 
selenium accumulation and glutathione S-transferase activity 
in vivo,40 as summarized in Tables 1 and 2. Based on these 
studies, it can be inferred that transformation into nanorods is 
responsible for the observed reduction in bioavailability, and 
that heat treatment to the 44 nm selenium nanoparticles would 
reduce its bioactivity, other than bioavailability.
As a novel supplemental agent with a reduced risk of sele-
nium toxicity, selenium nanoparticle solution may be added 
to functional foods, for which the final products could require 
heat processing. The present results suggest that temperature 
and duration of heat processing, as well as original nano-
particle size, should be carefully selected when a selenium 
nanoparticle solution is added to functional foods, in order to 
conserve fully the bioactivity of the selenium nanoparticles. 
A selenium nanoparticle solution after heat treatment can be 
monitored for alterations in the size and structure of the nano-
particles, in addition to changes in nutritional parameters/
biomarkers. Normally, selenium is supplemented in food at 
very low levels; it is not possible to observe selenium nano-
particles by transmission electron microscopy in foods at such 
low concentrations. Thus, the results obtained from studies 
of selenium nanoparticle   solution as a surrogate for actual 
foods not only indicate alterations in nutritional parameters, 
but also link the   alterations to changes in   nanoscale size and 
structure. In addition, different foods would be processed 
by various types of heat treatment; we cannot address all 
the possible specific food processes in the present study. 
  However, the results obtained using the selenium nanopar-
ticle solution as a model can justify the general guideline 
that caution should be used when selenium nanoparticles are 
added to foods which need to be heated during processing. 
Based on the results of the present study, in regard to food 
that has been supplemented with selenium nanoparticles, 
the best general method for drying would be lyophilization. 
Given that the thermostability of selenium nanoparticles is 
size-dependent, smaller selenium nanoparticles being more 
resistant than larger selenium nanoparticles to transforma-
tion into nanorods during heat treatment, there is also the 
strong implication that the use of smaller size selenium 
nanoparticles in foods is essential if extensive heat exposure 
is unavoidable. On the other hand, some food heat processes 
involve lower temperature conditions than those required to 
affect selenium nanoparticle structure and bioavailability. 
For example, to prepare selenium capsules, 1 mL selenium 
nanoparticle solution (400 µg/mL) is added to 2 g starch, 
and this mixture could be dried at 60°C for 40 minutes 
with an airblast. Milk sterilization involves heat treatment 
at 62°C for 30 minutes. To mimic these processes, we 
observed the impact of heat treatment at 60°C for 40 minutes 
on a 31 nm selenium nanoparticle solution. As shown in 
Supplementary Figure 1, such a moderate heat process did 
not alter the size of the selenium nanoparticles. Thus, as 
Table 1   Comparison  of  bioactivity  of  selenium  nanoparticles 
with different sizes in vitro and in vivo at nutritional levels (small 
5–15 nm, medium 20–60 nm, large 80–200 nm)
In vitro and in vivo models Size effects Reference
In vitro models by ESR spectra detection
Scavenging AAPH-generated radical S . M . L 48
Scavenging DPPH radical S . M . L 48
Scavenging superoxide radical S . M = L 48
Scavenging singlet oxygen M . L 48
Attenuating Cu2+-induced  
DNA damage
S . M . L 48
HepG2 cells
Increasing GPx activity S = M = L 47
Increasing PHGPx activity S = M = L 47
Increasing TrxR activity S = M = L 47
Selenium-deficient mice
Increasing hepatic selenium S = M = L 47
Increasing hepatic GPx activity S = M = L 47
Increasing hepatic TrxR activity S = M = L 47
Abbreviations:  ESR,  electron  spin  resonance;  AAPH,  2,2′-azo-bis-(2-
amidinopropane)  hydrochloride;  DPPH,  1,1-diphenyl-2-picryhydrazyl;  GPx, 
glutathione peroxidase; PHGPx, phospholipid hydroperoxide glutathione peroxidase; 
TrxR, thioredoxin reductase; S, small; M, medium; L, large.
Table 2 Comparison of bioactivity of 36 nm and 90 nm selenium 
nanoparticles at supranutritional levels
Oral selenium  
nanoparticle doses in mice
Size effects in term  
of increase
Reference
0.5 mg/kg for 7 days Blood selenium  
36 nm . 90 nm
40
0.5 mg/kg for 7 days Hepatic GST activity  
36 nm . 90 nm
40
2 mg/kg for 7 days Blood selenium  
36 nm . 90 nm
40
2 mg/kg for 7 days Hepatic selenium  
36 nm . 90 nm
40
2 mg/kg for 7 days Hepatic GST activity  
36 nm . 90 nm
40
5 or 10 mg/kg once,  
monitored at 24 or 72 hours
Blood selenium  
36 nm . 90 nm
40
5 or 10 mg/kg once,  
monitored at 24 or 72 hours
Hepatic selenium  
36 nm . 90 nm
40
5 or 10 mg/kg once,  
monitored at 72 hours
Hepatic GST activity  
36 nm . 90 nm
40
Abbreviation: GST, glutathione.
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  compared with the use of inorganic selenium salts (where 
heat is not a consideration), the potential disadvantages of 
using selenium nanoparticles when a heat process is required 
can potentially be overcome, provided nanoscale size and 
heat treatment conditions are carefully selected.
Conclusion
Heat treatment has a significant impact on the size,   structure, 
and bioactivity of selenium nanoparticles. In general, the 
sizes of selenium nanoparticles increase and bioactivities 
decrease when a selenium nanoparticle solution is subjected 
to heat treatment. However, the thermally-activated size 
and structure evolution are substantially dependent upon 
precursor particle size, with smaller selenium nanoparticles 
being more resistant than larger selenium nanoparticles to 
transformation into nanorods during heat treatment.
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Figure S1 Impact of heat treatment on size and structure of 31 nm selenium nanoparticles. (A) Unheated precursor selenium nanoparticles. (B) Precursor selenium 
nanoparticle solution after heating at 60°C for 40 minutes. (C) Size before and after heat treatment.
Note: Data are presented as the mean ± standard deviation (n = 70).
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